Artiva Biotherapeutics, Inc. (ARTV)
11.03
+0.79
(+7.71%)
USD |
NASDAQ |
May 01, 15:40
Artiva Biotherapeutics Market Cap : 270.73M for May 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 276.82B |
| Regeneron Pharmaceuticals, Inc. | 73.70B |
| Innoviva, Inc. | 1.718B |
| Rocket Pharmaceuticals, Inc. | 387.59M |
| ACADIA Pharmaceuticals, Inc. | 3.717B |
Market Cap Related Metrics
| PEG Ratio | -0.1937 |
| Price to Book Value | 2.462 |
| Price | 11.03 |
| Earnings Yield | -31.11% |
| PEGY Ratio | -0.1937 |